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Abstract
Background: Intact Toll-like receptor 4 (TLR4) has been identified in hepatic stellate cells (HSCs), the primary
fibrogenic cell type in liver. Here, we investigated the impact of TLR4 signaling on the gene expression network of
HSCs by comparing the transcriptomic changes between wild-type (JS1) and TLR4 knockout (JS2) murine HSCs in
response to two TLR4 ligands, lipopolysacchride (LPS), or high-mobility group box 1 (HMGB1).
Results: Whole mouse genome microarray was performed for gene expression analysis. Gene interaction and
co-expression networks were built on the basis of ontology and pathway analysis by Kyoto Encyclopedia of
Genes and Genomes (KEGG). Gene expression profiles are markedly different between Wild type (JS1) and TLR4 knockout
(JS2) HSCs under basal conditions or following stimulation with LPS or HMGB1. The differentially expressed genes
between TLR4 intact and null HSCs were enriched in signaling pathways including p53, mTOR, NOD-like receptor,
Jak-STAT, chemokine, focal adhesion with some shared downstream kinases, and transcriptional factors. Venn analysis
revealed that TLR4-dependent, LPS-responsive genes were clustered into pathways including Toll-like receptor and
PI3K-Akt, whereas TLR4-dependent, HMGB1-responsive genes were clustered into pathways including
metabolism and phagosome signaling. Genes differentially expressed that were categorized to be TLR4-dependent and
both LPS- and HMGB1-responsive were enriched in cell cycle, ubiquitin mediated proteolysis, and mitogen-activated
protein kinase (MAPK) signaling pathways.
Conclusions: TLR4 mediates complex gene expression alterations in HSCs. The affected pathways regulate a wide
spectrum of HSC functions, including inflammation, fibrogenesis, and chemotaxis, as well as cell growth and metabolism.
There are common and divergent regulatory signaling downstream of LPS and HMGB1 stimulation via TLR4 on HSCs.
These findings emphasize the complex cascades downstream of TLR4 in HSCs that could influence their cellular biology
and function.
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Background
Hepatic stellate cells (HSCs) are the predominant extra-
cellular matrix-producing cell type in the liver [1–5].
The activation of HSCs is the central event in fibrogenesis
that drives fibrosis, cirrhosis, and hepatic decompensation.
Following liver injury, the activated HSC adopts a
myofibroblast-like phenotype to produce collagen and
other extracellular matrix (ECM) components. Activated
HSCs also express the intracellular microfilament protein
α-smooth muscle actin (α-SMA) and tissue inhibitor of
metalloproteinases (e.g., tissue inhibitor of metalloprotein-
ase (TIMP)-1), the latter of which inhibits matrix degrad-
ation. The cells acquire chemotactic abilities, which
confer upon them the potential to migrate and accumu-
late. HSCs release profibrogenic and promitogenic cyto-
kines (e.g., TGFβ1 and PDGF), which stimulate ECM
production and drive proliferation in an autocrine manner
[6]. Activated HSCs are resistant to apoptotic stimuli and
express pattern recognition receptors, specifically Toll-like
receptors 4 (TLR4) and 9 (TLR9), and respond to their
ligands to activate downstream signalling pathways and
transcriptional factors (TFs).
TLR4 is a member of the pattern recognition receptor
superfamily. It plays an important role in recognizing bac-
terial lipopolysaccharide (LPS) and mediating inflamma-
tory responses and innate immunity [7, 8]. TLR4 signals
through the adaptor protein MyD88 in activating down-
stream effectors that include nuclear factor-κB (NF-κB),
mitogen-activated protein kinase (MAPKs), and phos-
phatidylinositol 3-kinase (PI3K), leading to the production
of pro-inflammatory cytokines. The MyD88-independent
pathway is associated with the induction of IFN-β- and
IFN-inducible genes. In addition to its exogenous ligand,
LPS, there are endogenous TLR4 ligands from cellular
compartments that are increased during tissue injury.
Notably, high-mobility group box 1 (HMGB1), a chroma-
tin associated highly conserved nuclear protein, may serve
as an extracellular signaling molecule and damage associ-
ated molecular pattern molecule (DAMP) that activates
Toll-like receptor signaling [9, 10]. HMGB1 is passively
released from necrotic cells and is actively secreted by
inflammatory cells, mediating the response to inflam-
mation, immunity, chemotaxis, and tissue regeneration
[11–18]. The level of HMGB1 is increased in the serum
of chronic hepatitis patients [19] and in the livers of
experimental liver fibrosis [20]. Increased levels of
HMGB1 are closely associated with the severity of
inflammation and fibrosis [20].
HSCs have intact TLR4 signaling. They express LPS-
recognizing receptors including CD14, TLR4, and MD2
and respond to LPS with the activation of iκB kinase
(IKK)/NF-κB and JNK, as well as the secretion of pro-
inflammatory cytokines (e.g., IL-6 and TNF-α), chemo-
kines (e.g., MCP-1, MIP-2, RANTES, and CCR5), and
expression of adhesion molecules (ICAM-1) [21]. TLR4
signaling contributes to the activation of hepatic stellate
cells (HSC) by promoting an inflammatory phenotype,
fibrogenesis, and cell survival [22]. In culture, this cell
type responds to HMGB1 via TLR4, which subsequently
triggers inflammation and enhances fibrogenic responses
via downstream signaling [23], indicating that TLR4
signaling need not rely solely on gut-derived LPS for
activation during liver injury.
In this study, we have explored the broad impact of
TLR4 signaling on HSC gene expression and signaling
pathways and the common and differential effects of the
TLR4 activation by LPS or HMGB1, which represent the
exogenous and endogenous ligands of TLR4, respect-
ively. Through this effort, we seek to identify both the
common and differentially expressed genes of HSC in
response to different TLR4 ligands and to uncover the
key regulatory molecules.
Results
Comparison of the transcriptome of JS1 and JS2 cells
The transcriptomic changes within wild-type (JS1) and
TLR4 knockout (JS2) mouse stellate cell lines were in-
vestigated. The gene expression patterns of JS1 and JS2
cells were significantly different under basal conditions.
The genes that were 1.5-fold differentially expressed and
the numbers of Go terms that were enriched by these
genes are listed in Additional file 1: Table S1. The differ-
entially expressed genes included those linked to fibro-
genesis (Col I, Col III, FN1), matrix remodeling (TIMP2,
TIMP3, MMP2), growth factors and their receptors
(VEGFD, FGF7, IGF1 and IGF1R, PDGFα and
PDFGRα、PDGFR), chemokine and chemokine recep-
tors (CXCL12, CXCL11, of CXCR7), inflammation and
immune mediators (IL6), transcription factors and some
important signaling molecules (Jun, Stat3, MAPK1). The
expression of these genes was validated by qRT-PCR. A
high correlation was observed between q-PCR and
microarray data (Table 1).
Pathway analysis was used to uncover the significant
pathways within differentially expressed gene sets ac-
cording to the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database. Of the data set of differentially
expressed genes in JS1 compared to JS2, 682 up-regulated
genes and 773 down-regulated genes populated 17 up-
and 10 down-pathway categories, respectively. Seven of
the signaling pathways up-regulated in JS1 cells and corre-
lated with key HSC functions were p53, mTOR, NOD-like
receptor, Jak-STAT, chemokine, focal adhesion, and path-
ways in cancer (Table 2). Important down-regulated
signaling pathways included those regulating cell adhesion
molecules (CAMs), phagosome activity, axon guidance,
and antigen processing and presentation (Table 2).
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Table 1 Verification of gene expression changes by RT-qPCR
Gene
symbol




SP1 Specific protein 1 F:5′-ACTGAGATCCCCAAAACACC-3′;
R:5′-TTCTCTGCCCTCACTCTTGA-3′
2.00 3.81 Transcriptional factor




1.89 2.35 Transcriptional factor
Jun Jun proto-oncogene F:5′-CCTTCTACGACGATGCCCTC-3′;
R:5′-GGTTCAAGGTCATGCTCTGTTT-3′
3.01 3.94 Transcriptional factor
Fas Fas cell surface death receptor F:5′-GCAGACATGCTGTGGATCTGG-3′;
R:5′-TCACAGCCAGGAGAATCGCAG-3′
5.10 2.18 Transcriptional factor




75.96 42 Growth factor
BDNF Brain-derived neurotrophic factor F:5′-GCCTCCTCTACTCTTTCTGCTG-3′;
R:5′-TGTGACCCACTCGCTAATACTG-3′
2.68 5.76 Growth factor
VEGFD (FIGF) c-fos induced growth factor
(vascular endothelial growth factor D)
F:5′-AGCACCTCCTACATCTCCAAAC-3′;
R:5′-CATTCATCTTCTTCTGGGGTCT-3′
4.82 5.76 Growth factor
IGF1 Insulin-like growth factor 1 F:5′-AAAATCAGCAGCCTTCCAACT-3′;
R:5′-CCTGTGGGCTTGTTGAAGTAA-3′
2.17 3.13 Growth factor
PTN Pleiotrophin F:5′-CTCTGCACAATGCTGACTGTC-3′;
R:5′-CTTTGACTCCGCTTGAGGCTT-3′
31.78 36 Growth factor
PDGFα Platelet-derived growth factor, alpha F:5′-TGGCTCGAAGTCAGATCCACA-3′;
R:5′-TTCTCGGGCACATGGTTAATG-3′
1.61 1.229 Growth factor
IGFBP3 Insulin-like growth factor binding protein 3 F:5′-TCCAGGAAACATCAGTGAGTCCGA-3′;
R:5′-CATACTTGTCCACACACCAGCAGA-3′
22.75 27.84 Insulin-like growth
factor binding protein
Col I collagen, type I F:5′-GCTCCTCTTAGGGGCCACT-3′;
R:5′-CCACGTCTCACCATTGGGG-3′
3.56 1.6 Fibrogenesis
FN1 Fibronectin 1 F:5′-TTCAAGTGTGATCCCCATGAAG-3′;
R:5′-CAGGTCTACGGCAGTTGTCA-3′
7.34 5.26 Fibrogenesis
TIMP2 Tissue inhibitors of metalloproteinase 2 F:5′-CTGGACGTTGGAGGAAAGAAG-3′;
R:5′-CTGGGTGATGCTAAGCGTGTC-3′
2.01 3.456 Matrix remodeling
TIMP3 Tissue inhibitors of metalloproteinase 3 F:5′-GCAAGGGCCTCAATTACCG-3′;
R: 5′-AGGCGTAGTGTTTGGACTGATA-3′
8.57 10.389 Matrix remodeling
MMP2 Matrix metalloproteinase 2 F:5′-GTGTCTTCCCCTTCACTTTCCT-3′;
R:5′-CATCATCGTAGTTGGTTGTGGT-3′
8.07 10.24 Matrix remodeling
IL6 Interleukin 6 F:5′-GGAGAGGAGACTTCACAGAGGA-3′;
R:5′-ATTTCCACGATTTCCCAGAGA-3′
3.00 1.74 Inflammatory factor
CXCR7 Chemokine (C-X-C motif) receptor 7 F:5′-AGCCTGGCAACTACTCTGACA-3′;
R:5′-GAAGCACGTTCTTGTTAGGCA-3′
11.31 14.42 Chemokine receptor
CXCL11 Chemokine (C-X-C motif) ligand 11 F:5′-GGCTTCCTTATGTTCAAACAGGG-3′;
R:5′-GCCGTTACTCGGGTAAATTACA-3′
2.03 0.65 Chemokine
CXCL12 Chemokine (C-X-C motif) ligand 12 F:5′-ACTGTGCCCTTCAGATTGTTG-3′;
R:5′-CAGCCTTTCTCTTCTTCTGTCG-3′
44.84 34.95 Chemokine
CASP2 Caspase 2 F:5′-GCAAGATGGAAAGAACCACAC-3′;
R:5′-GCAAGATGGAAAGAACCACAC-3′
1.83 1.7 Apoptin
DLK1 Delta-like 1 homolog (Drosophila) F:5′-AGTGCGAAACCTGGGTGTC-3′;
R:5′-GCCTCCTTGTTGAAAGTGGTCA-3′
18.95 19.784 Tumor repressor,
cell differentiation






GNG2 Guanine nucleotide binding protein
(G protein), gamma 2
F:5′-GAAGCCAACATCGACAGGAT-3′;
R:5′-GTTTTCTGAGGCTGGGACTG-3′
5.71 5.5 Signaling transduction
MDM2 E3 ubiquitin protein ligase F:5′-AGATCCTGAGATTTCCTTAGCTGACT-3′;
R:5′-TCTCACGAAGGGTCCAGCATCT-3′
3.77 4 Ubiquitination




2.35 3.73 Modulator of
Wnt signaling
*P < 0.05, gene mRNA expression in JS1 cells when compared to JS2
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To illustrate the effect of TLR4 on biological functions
of HSCs, we built the gene-act-network according to the
relationship between the differentially expressed genes in
TLR4 intact and null HSC using the KEGG database
(Fig. 1). Protein complexes and functional modules were
distinguished which have different biological implications.
In this network of gene–gene interaction, the genes that
were the central regulatory factors due to a strong degree
of centrality (degree >5) were listed in Table 2. Specifically,
Ccnd1, Igf1, MAPK family members (MAPK1, MAPK12,
MAP3K7), Rps6ka1, Pik3r3, Jak2, Stat5, Stat3, PDGFRα
and β, Prkca, Gsk3b, Fn1, Itgβ7, JUN, H-ras, and multiple
histocompatibility complex molecules (H2-M2, H2-Q7,
H2-Q2, LOC547349) were involved in the previously
mentioned pathways.
By co-expression network analysis, four networks were
identified in JS1 cells using differentially expressed genes
populating the pathways category. There were 172 genes
related to one another. Likewise, three networks were
identified in JS2 cells (Additional file 2: Figure S1). Core
regulatory factors that involved in the differential net-
works were determined by the degree differences be-
tween the JS2 and JS1 cells. Genes that displayed degree
differences more than 5 are shown in Table 2. Of note,
some of the genes identified to be core regulatory factors
in co-expression networks were also the central regula-
tory factors in gene-act-network, indicating their import-
ant role in the differentially expressed gene spectrums in
JS1 and JS2 cells. These included Rps6ka1, Jak2, Stat5,
Il6st, Prkca, Fn1, GSk3b, PDGFRα and β, Itgβ7, and






P value No. of
DifGenes



















+1.511 0.049774 25 Jak2,Stat5b,Stat5a, Il6st, Pik3r3,
Akt3,Ptpn11,Stat3,Ifnar1,Stat6, Stat2
Jak2, Stat5a, Stat5b,




+1.489 0.042555 29 Jak2,Prkacb, Gsk3b, Mapk1, Kras, Plcb3, Gnai3,





+1.469 0.025892 39 Pdgfra, Pdgfrb, Prkca, Gsk3b, Fn1, Mapk1, Itga11,
Igf1r, Jun,Akt3, Igf1, Tnc, Braf, Col5a1, Col3a1, Col1a2,
Col1a1, Thbs3, Thbs1, Col6a2, Col6a1, Col4a6, Tln2,
Ugdh
Pdgfra, Pdgfrb, Prkca,




+1.350 0.032167 57 Pdgfra, Pdgfrb, Prkca, Grb2, Gsk3b, Fn1, Pik3r3,
Egfr, Mapk1, Kras, Jun, Akt3, Igf1, Braf, Stat5b, Stat5a,
Figf, Cdk4, Stat3, Pias1, Mdm2
Pdgfra, Pdgfrb, Prkca,







−1.493 0.046196 28 H2-M2, LOC547349, H2-Q7, H2-Q2, Itgb7, Sdc3,
LOC100044874, H2-M3, H2-T23, H2-T10, H2-K1, H2-





path:mmu04145 Phagosome −1.640 0.006056 41 H2-M2, H2-Q2, H2-Q7, LOC547349, LOC100044874,
H2-M3, H2-T23, H2-T10, H2-K1, H2-Q8, H2-Q6, H2-













−1.886 0.012941 21 H2-M2, H2-Q2, H2-Q7, LOC547349, LOC100044874,




Note: Genes that are identified to be key regulatory factors by both gene-act-net work and co-expression network analysis (degree or difference degree >5) are
marked in bold and italic font
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multiple histocompatibility complex molecules (H2-M2,
H2-Q7, H2-Q2, LOC547349) and are highlighted in
Table 2.
Comparison of the transcriptome between JS1 and JS2
cells in response to LPS
A total of 1392 different probes were tested with 849
up-regulated and 543 down-regulated in JS1 cells in
response to LPS stimulation. Gene ontology analysis indi-
cated that 69 up and 86 down gene ontology (GO) terms
were enriched (Additional file 1: Table S1). Pathway
analysis identified 261 up-regulated genes and 140 down-
regulated genes populated 10 up and 8 down pathways
categories, respectively. The signaling pathways up-
regulated in LPS-treated JS1 cells included Toll-like recep-
tor, neurotrophin signaling, glycolysis/gluconeogenesis,
and immune disease pathways (Table 3), with MAPKs
(MAPK9, MAPK14) and multiple MHC molecule (H2-
Q2); these were the core regulatory factors in gene-act-net
work (Additional file 3: Figure S2) and co-expression
network (Additional file 4: Figure S3), with the highest de-
gree and differential degree numbers. The down-regulated
signaling pathways included phosphatidylinositol signal-
ing, tight junction, and ubiquitin-mediated proteolysis,
with Prkca, Map3k1, and Herc1 as the core regulatory
factors (Table 3). The gene interaction and co-expression
Fig. 1 Gene-act-network analysis of the effect of TLR4 on the biological functions of hepatic stellate cells. The networks were built according to
the relationship between the differentially expressed genes in TLR4 intact and null HSC using the KEGG database. Green circles represented down-regulated
genes; red circles represent the up regulated genes;→ activation/association; —: compound; —|: inhibition. The sizes of the circles were correlated to the
degree numbers linked to the genes
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networks in TLR4 null cells post LPS stimulation were
significantly simpler and lacked core regulatory factors
(Additional file 3: Figure S2).
Comparison of the transcriptome of JS1 and JS2 cells in
response to HMGB1
A total of 1445 different probes were tested with 586
up-regulated and 859 down-regulated transcripts in JS1
cells in response to HMGB1 stimulation. Gene ontology
analysis indicated that 47 up and 95 down GO terms
were enriched (Additional file 1: Table S1). Pathway ana-
lysis identified 184 up-regulated genes and 219 down-
regulated genes populated 8 up- and 5 down-pathways
categories, respectively. Within the signaling pathways
up-regulated in HMGB1-treated JS1 cells, there were
glutathione metabolism and drug metabolism—cyto-
chrome P450 (Table 4), with Gpx4, Gstt2, and Odc1.
Cyp2e1 as the core regulatory factors in gene act net-
work (Additional file 5: Figure S4) and/or co-expression
network (Additional file 6: Figure S5), with highest de-
gree and differential degree numbers. Within the down-
regulated signaling pathways, there were ubiquitin-
mediated proteolysis, mTOR signaling, pathways in can-
cer, RIG-like receptor signaling pathway with Herc1 and
Traf6, Mapk1 and Rps6ka3, Ifg1r, Prkx, and Foxo1 as
the core regulatory factors (Table 4).
Similar to the response to LPS, the gene interaction
and co-expression networks in TLR4 null cells following
HMGB1 stimulation were also significantly simpler and
lacked core regulatory factors (Additional file 5: Figure
S4 and Additional file 6: Figure S5).
Venn analysis of TLR4-dependent LPS and HMGB1 re-
sponse in JS1 cells
In order to compare the common and differential TLR4-
dependent responses of JS1 cells to LPS and HMGB1,
we further performed Venn analysis to identify the com-
mon and specific transcriptomic responses and the gene
interactions of HSCs in response to LPS or HMGB1 via
TLR4 (Fig. 2).
Seven hundred fifty-four differentially expressed genes
were categorized to be TLR4-dependent and LPS-specific
responses. Among them, 179 up-regulated genes were
enriched into 25 up-regulated pathways including Toll-like
receptor, neurotrophin, MAPK, PI3K-Akt, TNF, Foxo, and
osteoclast differentiation (Fig. 3a), with Mapk9, Mapk14,
Map2k1, and Foxo3 as the core regulatory factors; on the
other hand, 77 down-regulated genes were enriched into 20
down-regulated pathways including phosphatidylinositol
signaling system, with Pik3r3 as a core regulatory factor
(Table 5, Fig. 4).
Eight hundred thirty-seven differentially expressed
genes were found to be TLR4-dependent and HMGB1-
specific responses. Within them, 94 up-regulated genes
were enriched into 27 up-regulated pathways including
glutathione metabolism, metabolic, neurotrophin, osteo-
clast differentiation, and phagosome signaling (Fig. 3b),
with the core regulatory molecules including Gstt2,
Table 3 KEGG pathway analysis for differentially expressed genes in JS1 cells with or without LPS treatments and the key regulatory
genes
Path Path Term Enrichment
(+, up; −, down)








+3.226 0.002679 10 Hk1 Gm5506, Tpi1, Ldha
path:mmu03420 Nucleotide excision
repair
+3.110 0.008222 8 / Rfc2, Ercc1, Cdk7




+2.224 0.018448 11 Mapk9, Mapk14 Mapk9, Mapk14
path:mmu04722 Neurotrophin signaling
pathway
+1.965 0.021031 14 Mapk14, Cdc42 Mapk14
path:mmu05320 Autoimmune thyroid
disease




path:mmu03030 DNA replication +2.757 0.032638 6 / Pola2
path:mmu04070 Phosphatidylinositol
signaling system
−3.880 0.003976 7 Prkca, Pik3r3 Prkca
path:mmu04530 Tight junction −2.431 0.025024 8 Prkca, Myl9 /
path:mmu04120 Ubiquitin mediated
proteolysis
−2.231 0.028651 9 Map3k1 Map3k1, Herc1, Prkca, Ubr5
Note: Genes that are identified to be key regulatory factors by both gene-act-network and co-expression network analysis (degree or difference degree >3) are
marked in bold and italic font
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Mgst3, Cyp2e1, MAPK3, Adcy5, Kras, H2-M11, and H2-
T24. One hundred seventy-three down-regulated genes
were enriched into 25 down-regulated pathways includ-
ing Foxo, long-term potentiation, mTOR, neurotrophin,
NOD-like receptor, PI3K-Akt, and ubiquitin-mediated
proteolysis signaling pathways, with MAPK1, Traf6,
Prkx, Igflr, Ptk2, Rps6k3, and Foxo1 as the core regula-
tory factors (Table 6, Fig. 4).
By Venn analysis, 403 differentially expressed genes
were clustered as TLR4-dependent and both LPS and
HMGB1 responsive; within them, 107 up-regulated
genes were enriched in 9 up-regulated pathways in-
cluding cell cycle, spliceosome, ribosome, glycolysis/
gluconeogenesis, fructose and mannose metabolism,
and purine metabolism (Fig. 3c), with TRP53, Ccnd2,
HK1, Ddx39b, and Ak2 as the core regulatory genes.
In addition, 50 down-regulated genes enriched to 5
down-regulated pathways, which included ubiquitin-
mediated proteolysis, protein processing in endoplas-
mic reticulum, and MAPK signaling pathways with
Herc1 and 4, Eif2s1, and Prkca and Map3k1 as the
core regulatory genes (Table 7, Fig. 4).
Discussion
In our previous study, immortalized mouse stellate cell
lines that were TLR4 wild-type (JS1) and TLR4 knockout
Table 4 KEGG pathway analysis for differentially expressed genes in JS1 cells with or without HMGB1 treatments and the key
regulatory genes
Path Path term Enrichment
(+, up; −, down)






path:mmu03410 Base excision repair +4.857 0.001406 7 / Nthl1, Mpg
path:mmu00480 Glutathione metabolism +3.001 0.022114 6 Gpx4,Gstt2,Gstp1,Mgst3,Gstp2 Gstt2, Gpx4, Odc1
path:mmu00982 Drug metabolism—cytochrome
P450
+2.805 0.028716 6 Gstt2,Cyp2e1, Mgst3,Gstp1 Gstt2, Cyp2e1
path:mmu04120 Ubiquitin-mediated proteolysis −2.378 0.003899 15 Traf6 Ube2n, Uba3, Herc1
path:mmu04150 mTOR signaling pathway −3.012 0.014331 7 Mapk1 Rps6ka3
path:mmu05200 Pathways in cancer −1.622 0.030471 22 Igf1r,Prkca,Mapk1,Ptk2 Rala, E2f3, Foxo1
path:mmu04622 RIG-I-like receptor signaling
pathway
−2.342 0.041959 7 Traf6 Cyld
Note: Genes that are identified to be key regulatory factors by both gene-act-network analysis and co-expression network analysis (degree or difference degree
>3) are marked in bold and italic font
Fig. 2 Venn analysis of the common and divergent TLR4-dependent genes expressed in response to LPS or HMGB1 stimuli. 1Lvs1N: number of
differentially expressed genes in JS1 cells in response to LPS stimulation, 2Lvs2N: number of differentially expressed genes in JS2 cells in response
to LPS stimulation, 1Hvs1N: number of differentially expressed genes in JS1 cells in response to HMGB1 stimulation, 2Hvs2N: number of
differentially expressed genes in JS2 cells in response to HMGB1 stimulation. The overlaps represent the common differentially expressed
genes in both treatments and/or cells
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(−/−) (JS2) were generated as a useful tool to further de-
lineate the functional role of TLR4 in HSCs [22]. JS2
cells were characterized by lack of LPS responsiveness
with lower NF-κB activation and pro-inflammatory cyto-
kine expression than JS1 cells. The TLR4 null cells also
showed reduced cell growth and lowered apoptotic
threshold following apoptotic stress. By comparing the
transcriptomes of these cell lines in the present study, it
is clear that TLR4 is critical in maintaining the gene-act-
network of HSCs, linking many important cellular sig-
naling pathways, including focal adhesion, p53, NOD-
like receptor, mTOR, chemokine, and Jak-STAT. All
these signaling pathways have been identified in HSCs
and have vital activities that are correlated to cell growth
Fig. 3 Pathway analysis for the common and divergent TLR4-dependent genes expressed in response to LPS or HMGB1 stimuli. A: The significant
pathways of the differentially expressed genes that were LPS responsive only in JS1 cells vs JS2 cells. B: The significant pathways of the differentially
expressed genes that were HMGB1responsive only in JS1 cells vs JS2 cells. C: The significant pathways of the differentially expressed genes that were
both LPS and HMGB1 responsive in JS1 cells vs JS2 cells. P value < 0.05 and FDR < 0.05 were used as a threshold to select significant KEGG pathways.
Y axis, enrichment of the significant pathway; X axis, KEGG pathway term
Table 5 Venn-analysis for pathways of differentially expressed genes that were LPS responsive only in JS1 cells vs JS2 cells and the
key regulatory genes





(+, up; −, down) core genes (degree >5)
PATH:04668 TNF signaling pathway 3.8644 0.0005 10 Mapk9, Mapk14, Map2k1
PATH:04722 Neurotrophin signaling pathway 3.7442 0.0002 12 Mapk9, Foxo3, Mapk14, Map2k1
PATH:04621 NOD-like receptor signaling pathway 3.4526 0.0195 5 Mapk9, Mapk14
PATH:04620 Toll-like receptor signaling pathway 3.3364 0.0044 8 Mapk9, Mapk14, Map2k1
PATH:04622 RIG-I-like receptor signaling pathway 3.0523 0.0301 5 Mapk9, Mapk14
PATH:04066 HIF-1 signaling pathway 3.03588 0.0074 8 Map2k1
PATH:04068 FoxO signaling pathway 2.8081 0.0075 9 Mapk9, Foxo3, Mapk14, Map2k1
PATH:04141 Protein processing in endoplasmic reticulum 2.4924 0.0106 10 Mapk9
PATH:04380 Osteoclast differentiation 2.3217 0.0396 7 Mapk9, Mapk14, Map2k1
PATH:04010 MAPK signaling pathway 2.0206 0.0189 13 Mapk9, Mapk14, Map2k1
PATH:04151 PI3K-Akt signaling pathway 1.8052 0.0291 15 Foxo3, Map2k1
PATH:04066 HIF-1 signaling pathway -3.5287 0.0321 4 Pik3r3
PATH:04070 Phosphatidylinositol signaling system -6.0445 0.0021 5 Ocrl, Pik3r3, Synj2
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and survival, fibrogenic function, inflammatory pheno-
type, and immune regulation [24–34]. By gene-act-
network analysis and/or co-expression network analysis,
some of the signaling pathways shared key regulatory
genes, for example, MAPK for focal adhesion, NOD-like
receptor, mTOR, pathway in cancer signaling pathways,
and transcriptional factor Jun for focal adhesion and
pathways in cancer, STAT5 for JAK-STAT and chemo-
kine signaling pathways. Based on these findings, loss of
TLR4 in HSCs would attenuate the activities of other
signaling pathways that share common downstream ki-
nases and transcription factors.
The transcriptomic analysis also revealed that there
were down-regulated genes in JS1 cells compared to JS2
cells, which were enriched within pathways of CAMs,
phagosome, axon guidance, and antigen processing and
presentation, with MHC I molecule LOC547349 and
MHC II molecules including H2-M2, H2-Q7, and H2-
Q2 as the key regulatory genes. Future studies should be
performed to determine the exact impact of TLR4 on
the antigen processing and immune inhibitory function
of HSCs [35–38]. In addition, the present study also
identified the co-expression of genes (e.g., Sema3a;
Sema4f, Ephb3, Hras1, Nfatc2) that belonged to axon
guidance pathway ordinarily found in neuronal cells.
This is in line with the findings that HSCs express
neural crest makers such as glial fibrillary acidic protein
(GFAP), as well as neurotrophins and their receptors,
which has suggested that HSCs might have a neural
crest origin.
Fig. 4 Venn analysis to identify the common and specific transcriptomic responses and the gene interaction of HSCs to LPS or HMGB1 via TLR4.
Green circles represented differentially expressed genes belong to LPS responsive only in JS1 cells vs JS2 cells. Blue circles represented differentially
expressed genes belong to HMGB1 responsive only in JS1 cells vs JS2 cells. Red circles represented the differentially expressed genes belong to
both LPS and HMGB1 responsive in JS1 cells vs JS2 cells
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Our previous study demonstrated that HMGB1, a key
DAMP molecule, may activate HSCs in a TLR4-MyD88-
dependent manner by enhanced activities of downstream
transcriptional factors NF-κВ and AP-1 and through the
expression and secretion of the target gene MCP-1. The
HMGB1 response is similar but weaker than effects elic-
ited by LPS [23]. It has been unclear whether the TLR4
ligand effect of HMGB1 differs from that of exogenous
TLR4 ligands on the gene expression networks of HSCs.
In the present study, especially by the Venn analysis of
the common and specific transcriptomic responses of
HSCs to LPS or HMGB1 via TLR4 (i.e., the genes ex-
pression responsiveness only in JS1 but not in JS2), there
are clearly TLR4-dependent and LPS-specific responsive
genes that were enriched within pathways including
Toll-like receptor, neurotrophin, MAPK, PI3K-Akt, and
TNF. These signaling pathways typically respond to
exogenous and endogenous ligands, cytokines, or
hypoxia stress, and signal through MAPK, JNK, and/or
NF-κB, to regulate the expression of genes with various
functions including inflammation and immunity, homeo-
stasis, cell-cycle control, metabolism, and oxidative stress
resistance. On the other hand, the up-regulated TLR4-
dependent and HMGB1-specific responsiveness genes were
enriched within pathways of glutathione metabolism,
metabolic, neurotrophin, and phagosome signaling, in-
dicating a specific role of HMGB1 via TLR4 in provok-
ing the system of cellular response to reactive oxygen
intermediate and xenobiotics.
Our data indicate that there are differentially expressed
genes that are TLR4-dependent and both LPS- and
HMGB1-responsive. The common up-regulated genes
were enriched to cell cycle, spliceosome, ribosome, and
metabolism, which may reflect the active cellular
responses to TLR4 ligands in wild-type HSCs, leading to
extensive gene expression and protein synthesis and
Table 6 Venn analysis for pathways of differentially expressed genes belong to HMGB1 treatment only in JS1 cells vs JS2 cells, and
the key regulatory genes
Pathway ID Pathway term Enrichment (+, up; −, down) P value No. of DifGenes Gene-act-net core genes (degree >5)
PATH:00480 Glutathione metabolism 4.2971 0.0380 3 Gstt2, Mgst3
PATH:04145 Phagosome 3.6668 0.0026 8 H2-M11, H2-T24
PATH:04722 Neurotrophin signaling pathway 3.5650 0.0094 6 Mapk3, Kras, Irs1
PATH:04380 Osteoclast differentiation 3.1579 0.0264 5 Mapk3
PATH:04068 FoxO signaling pathway 2.9708 0.0327 5 Mapk3, Kras, Irs1
PATH:01100 Metabolic pathways 1.6410 0.0234 25 Pold4, Polr3h, Cyp2e1, Pip5k1c
PATH:04151 PI3K-Akt signaling pathway −1.7433 0.0427 14 Mapk1, Igf1r, Ptk2, F2r, Irs1, Chuk
PATH:05205 Proteoglycans in cancer −2.1213 0.0215 11 Mapk1, Igf1r, Ptk2, Prkx
PATH:04068 FoxO signaling pathway −2.2599 0.0443 7 Mapk1, Igf1r, Foxo1, Irs1, Chuk
PATH:04722 Neurotrophin signaling pathway −2.2599 0.0443 7 Mapk1, Traf6, Irs1, Rps6ka3
PATH:05200 Pathways in cancer −2.3845 0.0014 18 Mapk1, Igf1r, Ptk2, Traf6, Foxo1, Chuk
PATH:04120 Ubiquitin mediated proteolysis −2.8018 0.0075 9 Traf6, Wwp1
PATH:04720 Long-term potentiation −3.1582 0.0267 5 Mapk1, Prkx, Rps6ka3
PATH:04150 mTOR signaling pathway −4.0231 0.0056 6 Mapk1, Irs1, Rps6ka3
PATH:04621 NOD-like receptor signaling pathway −4.2869 0.0042 6 Mapk1, Traf6, Chuk'
Table 7 Venn analysis for pathways of differentially expressed genes belong to both LPS and HMGB1 treatment in JS1 cells vs JS2
cells, and the key regulatory genes
Pathway ID Pathway term Enrichment
(+, up; −, down)
P value No. of DifGenes Gene-act-net core genes (degree >5)
PATH:03420 Nucleotide excision repair 4.6978 0.0308 3 Pold2
PATH:00010 Glycolysis/gluconeogenesis 4.3364 0.0171 4 Hk1
PATH:03040 Spliceosome 3.5744 0.0052 7 Ddx39b
PATH:04110 Cell cycle 2.7963 0.0403 5 TRP53, Ccnd2
PATH:00230 Purine metabolism 2.4022 0.0476 6 Pde2a, Polr2f, Ak2
PATH:04010 MAPK signaling pathway −3.3387 0.0133 6 Prkca, Map3k1, Hspb1
PATH:04141 Protein processing in endoplasmic reticulum −4.4615 0.0075 5 Eif2s1
PATH:04120 Ubiquitin-mediated proteolysis −5.3857 0.0035 5 Map3k1
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modification. Within the core regulatory genes identified,
there were TRP53, Ccnd2, HK1, Ddx39b, and Ak2. These
genes, especially TRP53, respond to diverse cellular
stresses and regulate expression of target genes that are
related to cell cycle arrest, apoptosis, senescence, DNA
repair, or metabolism. In addition to the common up-
regulated genes, the common TLR4-dependent down-
regulated genes by LPS and HMGB1 were enriched within
pathways including ubiquitin-mediated proteolysis, pro-
tein processing in endoplasmic reticulum, and MAPK
signaling pathways. These may function in TLR4 down-
stream responses to either activate the downstream cas-
cades or limit the responses as a feedback self-regulation,
such as the down-regulation of Map3k1 and Prkca, which
are the key components in MAPK signaling. These com-
plex cascades illustrate how transcriptional regulation in
HSCs is finely tuned and controlled by widely divergent
regulatory pathways.
Conclusions
The present study has demonstrated that TLR4 mediates
an integrated signal transduction cascade linking many
other important signaling pathways and function of
HSCs. There are complex gene expression alterations
subsequent to the loss of TLR4 in HSCs. Therefore, this
signaling pathway regulates a wide spectrum of HSC
functions, including inflammatory, fibrogenic, and
chemotactic properties, as well as cell growth and me-
tabolism. There are common and different regulatory
signaling downstream of LPS and HMGB1 stimuli via
TLR4 on HSCs. These findings emphasize the complex
cascades downstream of TLR4 in the HSC that have sig-
nificant consequences on its cell biology and function.
Methods
Cell treatment and RNA preparation
Immortalized wild-type (JS1) and TLR4−/− (JS2) mouse
HSC lines have been described in our previous study
[22]. They were subcultured in 6-well plates (1 × 105/ml
per well) to 80 % confluence and divided into the nega-
tive control, LPS-, and HMGB1-treated groups. The
cells were treated with phosphate buffer solution (PBS),
100 ng/ml LPS (purified lipopolysaccharides from
Escherichia coli serotype 0111:B4, Sigma-Aldrich, St.
Louis, MO, USA), or 100 ng/ml HMGB1 (Sigma), re-
spectively, and collected at 24 h after treatment for RNA
analysis. The cells were next treated with Trizol Reagent
(Invitrogen, Carlsbad, CA, USA) and stored at −70 °C
prior to RNA extraction. Total RNA extraction from
three biological repeats of the cells was performed ac-
cording to the manufacturer’s standard instructions
(Invitrogen), and then, the RNA was prepared and puri-
fied using RNeasy Mini Kit (QIAGEN, Valencia, CA).
RNA concentration was assessed by NanoDrop ND-1000
spectrophotometry (Thermo). High RNA quality was veri-
fied by formaldehyde denaturation electrophoresis.
Microarray hybridization
The Agilent Array platform was employed for micro-
array analysis of the RNA samples. The sample prepar-
ation and microarray hybridization were performed
based on the manufacturer’s standard protocols. Briefly,
1 μg of total RNA from each sample was amplified and
transcribed into fluorescent cRNA with using the manu-
facturer’s Agilent’s Quick Amp Labeling protocol (ver-
sion 5.7, Agilent Technologies). The labeled cRNAs
were hybridized onto the Whole Mouse Genome Oligo
Microarray (4x44K, Agilent Technologies). The arrays
were scanned by the Agilent Scanner G2505B.
Data analysis
Agilent Feature Extraction software (version 11.0.1.1)
was used to analyze acquired array images. Quantile
normalization and subsequent data processing were per-
formed using the GeneSpring GX v11.5.1 software pack-
age (Agilent Technologies). Limma algorithm was used
to screen the differentially expressed genes. The dif-
ferentially expressed genes were selected according to
the P value threshold (P < 0.05), followed by a second-
ary selection of >log1.5-fold difference.
GO analysis
Fisher test was carried out for the analysis of significant
gene ontology (GO-Analysis), which is a functional ana-
lysis associating differentially expressed genes with GO
categories. The GO categories are derived from Gene
Ontology (www.geneontology.org), which comprise three
structured networks of defined terms that describe gene
product attributes. The P value denotes the significance
of GO term enrichment in the differentially expressed
gene list. A P value ≤0.05 is considered to be significant.
Fisher’s exact test was used to classify the GO category,
and the false discovery rate (FDR) was calculated to cor-
rect the P value.
Pathway analysis
Pathway analysis was used to identify biological pathways
in which there is a significant enrichment of differentially
expressed genes according to latest KEGG database. Fisher’s
exact test followed by Benjamini–Hochberg (BH) multiple
testing correction was calculated to select the significant
pathway. Enrichment provides a measure of the significance
of the function, and the threshold of significance was
defined by P value and FDR.
Genes-act-network analysis
The differential genes that populated significant pathways
category were selected to build genes-act-network (Gene-
Ouyang et al. Fibrogenesis & Tissue Repair  (2016) 9:2 Page 11 of 13
Act-Net) according to the relationship between the genes,
proteins, and compounds in the KEGG database. The
flowchart of signaling transduction constructed by the
differential genes and the central key regulatory genes
were obtained by this analysis.
Co-expression network analysis
The differential genes that populated both the significant
pathways and GO category were selected to build gene co-
expression networks according to the normalized signal
intensity of specific expression genes. Pearson’s correlation
was calculated for each pair of genes, and the significant
correlation pairs were chosen to construct the network [39,
40] in both the control and case group. Core regulatory
factors were determined by the degree (the link numbers
one node has to the other) differences between the case
and control networks [41, 42]. Moreover, K-cores in graph
theory were introduced as a method of simplifying graph
topology analysis. A K-core of a network is a subnetwork in
which all nodes are connected to at least K other genes in
the subnetwork [41, 43].
Venn analysis
Venn analysis was used to analyze the common or dif-
ferential TLR4-dependent genes expression in response
to LPS or HMGB1 stimuli (Fig. 2). The differentially
expressed genes that were categorized to be TLR4-
dependent and LPS- or HMGB1-specific or common to
both were further processed by GO and pathway analysis
(Fig. 3) and build genes-act-network (Fig. 4).
Quantitative RT-qPCR
JS1 and JS2 HSCs were stimulated with saline vehicle
(control), 100 ng/ml LPS, or 100 ng/ml HMGB1 for
24 h as described above. Total RNA was extracted with
TRIzol reagent (Generay Biotech, Shanghai, China) and
then reverse transcribed to cDNA using a Prime-
ScriptTM RT reagent Kit (TaKaRa, Japan). Quantitative
real-time PCR analysis (RT-qPCR) was performed using
SYBR Green Realtime PCR Master Mix (Toyobo, Japan)
on a 7500 Real-Time PCR Systems (Applied Bio systems,
USA). The primer pairs were listed in Table 1. Data are
represented as the fold changes of the expression level
of the verified genes in JS1 cells relative to JS2 cells.
Statistical analysis
Statistical differences were analyzed with ANOVA using
SPSS software (17.0) (Chicago, IL, USA). The results
were represented as mean ± standard deviation (SD), and
the differences were considered statistically significant at
P < 0.05.
Additional files
Additional file 1: Table S1. A summary of transcriptomic analysis of
JS1 and JS2 cells. (DOCX 62 kb)
Additional file 2: Figure S1. Co-expression network analysis of JS1
(case) and JS2 cells (control) using differentially expressed genes that
populated the pathways category. (TIF 15343 kb)
Additional file 3: Figure S2. Gene-act-network analysis of the LPS
response in TLR4 intact JS1 (A) and null JS2 (B) hepatic stellate cells.
Green circles represented down-regulated genes; red circles represent
the up-regulated genes; → activation/association; —: compound; —|:
inhibition. The gene interaction network in TLR4 null cells post LPS
stimulation were significantly simpler and lacked core regulatory factors.
(TIF 3255 kb)
Additional file 4: Figure S3. Co-expression network analysis of the LPS
response in TLR4 intact JS1 (case) and null JS2 (control) hepatic stellate
cells. (TIF 6926 kb)
Additional file 5: Figure S4. Gene-act -network analysis of the HMGB1
response in TLR4 intact JS1 (A) and null JS2 (B) hepatic stellate cells.
Green circles represented down regulated genes; red circles represent
the up regulated genes; → activation/association; —: compound; —|:
inhibition. The gene interaction network in TLR4 null cells post HMGB1
stimulation were significantly simpler and lacked core regulatory factors.
(TIF 4371 kb)
Additional file 6: Figure S5. Co-expression network analysis of the
HMGB1 response in TLR4 intact JS1 (case) and null JS2 (control) hepatic
stellate cells. (TIF 5866 kb)
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